VistaGen Therapeutics, Inc. (VTGN): Price and Financial Metrics
VTGN Price/Volume Stats
| Current price | $2.36 | 52-week high | $4.21 |
| Prev. close | $2.37 | 52-week low | $1.90 |
| Day low | $2.33 | Volume | 83,800 |
| Day high | $2.42 | Avg. volume | 159,377 |
| 50-day MA | $2.32 | Dividend yield | N/A |
| 200-day MA | $2.77 | Market Cap | 68.11M |
VTGN Stock Price Chart Interactive Chart >
VistaGen Therapeutics, Inc. (VTGN) Company Bio
VistaGen Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops products for patients with diseases and disorders involving the central nervous system. VistaGen Therapeutics serves customers in the United States.
VTGN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VTGN Price Returns
| 1-mo | 4.89% |
| 3-mo | -14.49% |
| 6-mo | -8.88% |
| 1-year | -37.73% |
| 3-year | -92.85% |
| 5-year | -84.72% |
| YTD | -20.00% |
| 2024 | -42.61% |
| 2023 | 66.34% |
| 2022 | -94.72% |
| 2021 | 0.52% |
| 2020 | 181.28% |